P3596Dabigatran, rivaroxaban, and apixaban versus vitamin K antagonists for atrial fibrillation patients at low to intermediate stroke risk: a Danish nationwide cohort study | Zendy

AI Assistant Blog Pricing

P3596Dabigatran, rivaroxaban, and apixaban versus vitamin K antagonists for atrial fibrillation patients at low to intermediate stroke risk: a Danish nationwide cohort study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.